Journal article : Letter
A lower X-gate in TASK channels traps inhibitors within the vestibule
- Abstract:
- TWIK-related acid-sensitive potassium (TASK) channels—members of the two pore domain potassium (K2P) channel family—are found in neurons1, cardiomyocytes2,3,4 and vascular smooth muscle cells5, where they are involved in the regulation of heart rate6, pulmonary artery tone5,7, sleep/wake cycles8 and responses to volatile anaesthetics8,9,10,11. K2P channels regulate the resting membrane potential, providing background K+ currents controlled by numerous physiological stimuli12,13,14,15. Unlike other K2P channels, TASK channels are able to bind inhibitors with high affinity, exceptional selectivity and very slow compound washout rates. As such, these channels are attractive drug targets, and TASK-1 inhibitors are currently in clinical trials for obstructive sleep apnoea and atrial fibrillation16. In general, potassium channels have an intramembrane vestibule with a selectivity filter situated above and a gate with four parallel helices located below; however, the K2P channels studied so far all lack a lower gate. Here we present the X-ray crystal structure of TASK-1, and show that it contains a lower gate—which we designate as an ‘X-gate’—created by interaction of the two crossed C-terminal M4 transmembrane helices at the vestibule entrance. This structure is formed by six residues (243VLRFMT248) that are essential for responses to volatile anaesthetics10, neurotransmitters13 and G-protein-coupled receptors13. Mutations within the X-gate and the surrounding regions markedly affect both the channel-open probability and the activation of the channel by anaesthetics. Structures of TASK-1 bound to two high-affinity inhibitors show that both compounds bind below the selectivity filter and are trapped in the vestibule by the X-gate, which explains their exceptionally low washout rates. The presence of the X-gate in TASK channels explains many aspects of their physiological and pharmacological behaviour, which will be beneficial for the future development and optimization of TASK modulators for the treatment of heart, lung and sleep disorders.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, 24.6MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41586-020-2250-8
Authors
+ Biotechnology and Biological Sciences Research Council
More from this funder
- Grant:
- BB/N009274/1
- BB/N009274/1
- Publisher:
- Nature Research
- Journal:
- Nature More from this journal
- Volume:
- 582
- Issue:
- 7812
- Pages:
- 443-450
- Publication date:
- 2020-04-29
- Acceptance date:
- 2020-03-12
- DOI:
- EISSN:
-
1476-4687
- ISSN:
-
0028-0836
- Language:
-
English
- Keywords:
- Subtype:
-
Letter
- Pubs id:
-
1097771
- Local pid:
-
pubs:1097771
- Deposit date:
-
2020-03-31
Terms of use
- Copyright holder:
- Rödström et al.
- Copyright date:
- 2020
- Rights statement:
- © The Author(s), under exclusive licence to Springer Nature Limited 2020
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Nature Research at https://doi.org/10.1038/s41586-020-2250-8
If you are the owner of this record, you can report an update to it here: Report update to this record